Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.

Lee DC, Sunnarborg SW, Hinkle CL, Myers TJ, Stevenson MY, Russell WE, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Chang A, Jackson LF.

Ann N Y Acad Sci. 2003 May;995:22-38. Review.

PMID:
12814936
2.

Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability.

Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Lee DC.

J Biol Chem. 2002 Apr 12;277(15):12838-45. Epub 2002 Jan 31.

3.

Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25.

Cerretti DP, Poindexter K, Castner BJ, Means G, Copeland NG, Gilbert DJ, Jenkins NA, Black RA, Nelson N.

Cytokine. 1999 Aug;11(8):541-51.

PMID:
10433800
4.

An essential role for ectodomain shedding in mammalian development.

Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA.

Science. 1998 Nov 13;282(5392):1281-4.

5.

Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.

Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA.

J Biol Chem. 1998 Oct 23;273(43):27765-7.

6.

Expression and purification of correctly processed, active human TACE catalytic domain in Saccharomyces cerevisiae.

Clarke HR, Wolfson MF, Rauch CT, Castner BJ, Huang CP, Gerhart MJ, Johnson RS, Cerretti DP, Paxton RJ, Price VL, Black RA.

Protein Expr Purif. 1998 Jun;13(1):104-10.

PMID:
9631522
7.

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme.

Maskos K, Fernandez-Catalan C, Huber R, Bourenkov GP, Bartunik H, Ellestad GA, Reddy P, Wolfson MF, Rauch CT, Castner BJ, Davis R, Clarke HR, Petersen M, Fitzner JN, Cerretti DP, March CJ, Paxton RJ, Black RA, Bode W.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3408-12.

8.

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP.

Nature. 1997 Feb 20;385(6618):729-33.

PMID:
9034190
9.

Resonance assignments for Oncostatin M, a 24-kDa alpha-helical protein.

Hoffman RC, Moy FJ, Price V, Richardson J, Kaubisch D, Frieden EA, Krakover JD, Castner BJ, King J, March CJ, Powers R.

J Biomol NMR. 1996 Jun;7(4):273-82.

PMID:
8765735
10.

Direct evidence of a heterotrimeric complex of human interleukin-4 with its receptors.

Hoffman RC, Castner BJ, Gerhart M, Gibson MG, Rasmussen BD, March CJ, Weatherbee J, Tsang M, Gustchina A, Schalk-Hihi C, et al.

Protein Sci. 1995 Mar;4(3):382-6. Erratum in: Protein Sci 1997 Feb;6(2):494.

11.

Stoichiometry of the complex of human interleukin-4 with its receptor.

Hoffman RC, Schalk-Hihi C, Castner BJ, Gibson MG, Rasmussen BD, Zdanov A, Gustchina A, March CJ, Wlodawer A.

FEBS Lett. 1994 Jun 20;347(1):17-21.

12.

Alterations in thyrotropin (TSH) binding in iodine-deficient rats.

Clark OH, Lambert WR, Castner BJ.

J Surg Res. 1981 Feb;30(1):65-74. No abstract available.

PMID:
6257976
13.

Thyrotropin "receptors" in normal and neoplastic human thyroid tissue.

Clark OH, Castner BJ.

Surgery. 1979 Jun;85(6):624-32. No abstract available.

PMID:
451872
14.

Thyroid-stimulating hormone binding sites in benign and malignant thyroid tumors in man.

Clark OH, Castner BJ.

Surg Forum. 1977;28:135-7. No abstract available.

PMID:
617396

Supplemental Content

Loading ...
Support Center